CRINETICS PHARMACEUTICALS IN (CRNX) Stock Cash Flow
NASDAQ:CRNX - Nasdaq - US22663K1079 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -328.25M | -298.41M | -214.53M | -163.92M | -107.64M | |||
| Depreciation Amortization | 3.24M | 2.79M | 1.10M | 980.00K | 920.00K | |||
| Change In Working Capital | -594.00K | 11.63M | 8.04M | 18.61M | 1.10M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 64.04M | 58.02M | 39.08M | 29.12M | 17.04M | |||
| OPERATING CASH FLOW | -261.57M | -225.97M | -166.31M | -115.21M | -88.59M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.75M | -3.84M | -4.69M | -1.66M | -440.00K | |||
| Other Investing Activity | -657.34M | -570.97M | -195.72M | -172.32M | -56.05M | |||
| INVESTING CASH FLOW | -661.09M | -574.82M | -200.41M | -173.98M | -56.48M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 621.30M | 1.01B | 388.94M | 121.96M | 252.68M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 621.30M | 1.01B | 388.94M | 121.96M | 252.68M | |||
| CHANGE IN CASH | -301.36M | 209.65M | 22.22M | -167.23M | 107.61M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -261.57M | -225.97M | -166.31M | -115.21M | -88.59M | |||
| Capital Expenditure | -3.75M | -3.84M | -4.69M | -1.66M | -440.00K | |||
| FREE CASH FLOW | -265.32M | -229.81M | -171.00M | -116.87M | -89.03M | |||
All data in USD